Filter
706
Featured
75
147
Language
Document type
412
116
93
40
17
13
8
4
2
1
Countries
66
31
24
23
14
14
13
11
10
10
9
9
8
8
8
8
8
7
7
6
6
6
6
5
5
4
4
4
4
4
4
4
4
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
272
112
50
24
18
12
10
Toolboxes
80
53
46
38
28
24
23
22
21
18
16
14
12
7
5
4
4
3
3
3
1
1
Policy statement.
Document No. : FDA/SMC/SMD/GL-RAR/2013/01
Document No. : FDA/SMC/CTD/GL-CCT/2013/01
РУКОВОДСТВО ПО БИОЛОГИЧЕСКОЙ БЕЗОПАСНОСТИ ЛАБОРАТОРНЫХ ИССЛЕДОВАНИЙ ПРИ ТУБЕРКУЛЕЗЕ.
A survival guide for clinicans.
3rd edition.
The Zimbabwe National Pharmacovigilance Policy Handbook, 2nd Edition updates the November 2013 version to indicate the Zimbabwe National Pharmacovigilance (PV) Centre’s compliance with the WHO Pharmacovigilance Indicators Handbook 2015.
HRH Strategy for the Health Sector: 2012/13 – 2016/17
PLOS ONE | DOI:10.1371/journal.pone.0133869 July 28, 2015, p.1-16
PLoS Pathogens | www.plospathogens.org 1
February 2012 | Volume 8 | Issue 2 | e100246
Moving avidence into action
This document is part of a series of briefs for health program managers interested in implementing evidence-based programs. With a special emphasis on underutilized interventions, they present evidence on programs that work and provide guidance and resources for replicat
...
Guidelines for national programmes and other stakeholders
Annexes for webposting and CD-Rom distribution with the policy guidelines
WHO/CDS/TB/99.272
Document opérationnel technique sur la prévention et la prise en charge des cas de paludisme en République Démocratique du Congo (RDC)
